Focus On Execution Pays Off, Sets BMS Up For Growth In 2023

Sales Of Nine New Drugs Set To Double From 2022 Total

 
• By Mandy Jackson
two linear arrows up down icon
BMS expects to reverse its 2022 revenue decline with 2% growth in 2023 • Source: Shutterstock

More from Business

More from Scrip